Beijing-based developer of single-cell sorting and detection technology, offering full-chain single-cell sequencing solutions.
Established in 2015 and based in Beijing, China, SeekGene develops single-cell sorting detection technology. It has departments in Shanghai, Guangzhou, Chengdu, Wuhan and other places, and has cooperated with LaNova, Peking University People's Hospital and Peking University First Hospital. In January 2021, SeekGene raised over CNY 100 million in Series A funding led by BioTrack Capital. Its products include the SeekOne platform, the SeekGene Online analysis platform and the SeekSoul Tools analysis software.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in